Livermore, CA, United States of America

Brooke Nicole Harmon


Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Brooke Nicole Harmon: Innovator in Antibody Research

Introduction

Brooke Nicole Harmon is a prominent inventor based in Livermore, CA (US). She has made significant contributions to the field of antibody research, holding a total of 10 patents. Her work focuses on developing innovative solutions for targeting specific tissues in the human body.

Latest Patents

One of her latest patents involves lung-targeting single-domain antibodies and purification methods. This patent discloses single-domain antibodies (sdABs) designed to target human or mammalian lung tissue. The constructs and methods described include binding and transporting other sdABs or cargo with beneficial functionalities. Additionally, it outlines methods for treating, diagnosing, or prophylactically treating diseases, conditions, or malignancies. Another significant patent pertains to brain-targeting single-domain antibodies and purification methods. This invention provides sdAbs that can pass the blood-brain barrier, allowing for targeted treatment and diagnosis of brain-related conditions.

Career Highlights

Brooke Nicole Harmon is currently employed at National Technology & Engineering Solutions of Sandia, LLC. Her role at this esteemed organization allows her to further her research and development in the field of antibody technology.

Collaborations

Some of her notable coworkers include Yooli Kim Light and Maxwell Stefan. Their collaboration enhances the innovative environment in which they work, fostering advancements in antibody research.

Conclusion

Brooke Nicole Harmon is a trailblazer in the field of antibody research, with a focus on developing targeted therapies for critical health issues. Her contributions through her patents and work at Sandia, LLC, highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…